PMC:7696151 / 55734-55955
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1611 | 5-10 | Species | denotes | mouse | Tax:10090 |
| 1612 | 105-110 | Species | denotes | mouse | Tax:10090 |
| 1617 | 57-60 | Chemical | denotes | HCQ | MESH:D006886 |
| 1632 | 20-55 | Disease | denotes | obstetric antiphospholipid syndrome | MESH:D016736 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T359 | 0-221 | Sentence | denotes | In a mouse model of obstetric antiphospholipid syndrome, HCQ, administered in a daily dose of 200 μg per mouse limited placental abnormalities, with an increase of fetal survival, by inhibiting complement activation [95]. |